Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells

Radiation therapy plays an important role in the management of prostate carcinoma. However, the problem of radioresistance and molecular mechanisms by which prostate carcinoma cells overcome cytotoxic effects of radiation therapy remains to be elucidated. In order to investigate possible intracellular mechanisms underlying the prostate carcinoma recurrences after radiotherapy, we have established three radiation‐resistant prostate cancer cell lines, LNCaP‐IRR, PC3‐IRR, and Du145‐IRR derived from the parental LNCaP, PC3, and Du145 prostate cancer cells by repetitive exposure to ionizing radiation. LNCaP‐IRR, PC3‐IRR, and Du145‐IRR cells (prostate carcinoma cells recurred after radiation exposure (IRR cells)) showed higher radioresistance and cell motility than parental cell lines. IRR cells exhibited higher levels of androgen and epidermal growth factor (EGF) receptors and activation of their downstream pathways, such as Ras‐mitogen‐activated protein kinase (MAPK) and phosphatidyl inositol 3‐kinase (PI3K)‐Akt and Jak‐STAT. In order to define additional mechanisms involved in the radioresistance development, we determined differences in the proteome profile of parental and IRR cells using 2‐D DIGE followed by computational image analysis and MS. Twenty‐seven proteins were found to be modulated in all three radioresistant cell lines compared to parental cells. Identified proteins revealed capacity to interact with EGF and androgen receptors related signal transduction pathways and were involved in the regulation of intracellular routs providing cell survival, increased motility, mutagenesis, and DNA repair. Our data suggest that radioresistance development is accompanied by multiple mechanisms, including activation of cell receptors and related downstream signal transduction pathways. Identified proteins regulated in the radioresistant prostate carcinoma cells can significantly intensify activation of intracellular signaling that govern cell survival, growth, proliferation, invasion, motility, and DNA repair. In addition, such analyses may be utilized in predicting cellular response to radiotherapy.

[1]  R. Reddel,et al.  Inactivation of Tumor Suppressor p53 by Mot-2, a hsp70 Family Member* , 1998, The Journal of Biological Chemistry.

[2]  T. G. Grunewald,et al.  Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells. , 2006, Experimental cell research.

[3]  A. D'Amico,et al.  Guideline for the management of clinically localized prostate cancer: 2007 update. , 2007, The Journal of urology.

[4]  B. Blot,et al.  Alix (ALG-2-interacting Protein X), a Protein Involved in Apoptosis, Binds to Endophilins and Induces Cytoplasmic Vacuolization* , 2002, The Journal of Biological Chemistry.

[5]  S. Skvortsov,et al.  Identification of Endosomal Epidermal Growth Factor Receptor Signaling Targets by Functional Organelle Proteomics *S , 2007, Molecular & Cellular Proteomics.

[6]  S. Yeh,et al.  From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Hogg,et al.  Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase , 2000, Nature.

[8]  A. Maity,et al.  Cellular responses to EGFR inhibitors and their relevance to cancer therapy. , 2007, Cancer letters.

[9]  A. Sickmann,et al.  Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation , 2007, British Journal of Cancer.

[10]  D. Wessel,et al.  A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. , 1984, Analytical biochemistry.

[11]  M. Belechri,et al.  Correlation of nm23-H1 gene expression with clinical outcome in patients with advanced breast cancer. , 2007, In vivo.

[12]  B. Wilson,et al.  Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. , 2007, Neoplasia.

[13]  Z. Radisavljevic,et al.  TOR kinase and ran are downstream from PI3K/Akt in H2O2‐induced mitosis , 2004, Journal of cellular biochemistry.

[14]  K. Kelly,et al.  Activation of the RalGEF/Ral Pathway Promotes Prostate Cancer Metastasis to Bone , 2007, Molecular and Cellular Biology.

[15]  D. Feldman,et al.  The development of androgen-independent prostate cancer , 2001, Nature Reviews Cancer.

[16]  N. Curtin.  Therapeutic potential of drugs to modulate DNA repair in cancer , 2007, Expert opinion on therapeutic targets.

[17]  A. Garden,et al.  Combination of radiotherapy with EGFR antagonists for head and neck carcinoma , 2007, International Journal of Clinical Oncology.

[18]  A. Valentini,et al.  Effects of dutasteride on the expression of genes related to androgen metabolism and related pathway in human prostate cancer cell lines , 2007, Investigational New Drugs.

[19]  J. Fowler,et al.  Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: A 6-year follow-up , 2007, Acta oncologica.

[20]  Daohai Zhang,et al.  Proteomic Study Reveals That Proteins Involved in Metabolic and Detoxification Pathways Are Highly Expressed in HER-2/neu-positive Breast Cancer* , 2005, Molecular & Cellular Proteomics.

[21]  J. Hendry,et al.  Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers. , 1998, British Journal of Cancer.

[22]  Long Yu,et al.  Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal. , 2007, Biochemical and biophysical research communications.

[23]  T. Ulbright,et al.  Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. , 2001, Cancer research.

[24]  P. Giguère,et al.  Nm23-H2 Interacts with a G Protein-coupled Receptor to Regulate Its Endocytosis through an Rac1-dependent Mechanism* , 2004, Journal of Biological Chemistry.

[25]  R. Reddel,et al.  Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function. , 2000, Cancer research.

[26]  Henning Urlaub,et al.  Protein Composition and Electron Microscopy Structure of Affinity-Purified Human Spliceosomal B Complexes Isolated under Physiological Conditions , 2006, Molecular and Cellular Biology.

[27]  G. Bedogni,et al.  Subcellular Localization of APE1/Ref-1 in Human Hepatocellular Carcinoma: Possible Prognostic Significance , 2007, Molecular medicine.

[28]  J. An,et al.  Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor , 2007, Oncogene.

[29]  Anupama E. Gururaj,et al.  Signaling-dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1 , 2007, Proceedings of the National Academy of Sciences.

[30]  P. Fisher,et al.  Radiotherapy-induced signal transduction. , 2006, Endocrine-related cancer.

[31]  Frank Rose,et al.  Metastasis: the seed and soil theory gains identity , 2007, Cancer and Metastasis Reviews.

[32]  J. Venables.  Aberrant and Alternative Splicing in Cancer , 2004, Cancer Research.

[33]  S. Kambhampati,et al.  Growth factors involved in prostate carcinogenesis. , 2005, Frontiers in bioscience : a journal and virtual library.

[34]  L. Huber,et al.  Zooming in: Fractionation strategies in proteomics , 2004, Proteomics.

[35]  J. Meldolesi,et al.  Annexin2 coating the surface of enlargeosomes is needed for their regulated exocytosis , 2006, The EMBO journal.

[36]  G. Tell,et al.  The intracellular localization of APE1/Ref-1: more than a passive phenomenon? , 2005, Antioxidants & redox signaling.

[37]  U. Hellman.  Sample preparation by SDS/PAGE and in-gel digestion. , 2000, EXS.

[38]  M. Azodi,et al.  Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype. , 2005, Cancer research.

[39]  Paul Dent,et al.  Signal Transduction and Cellular Radiation Responses , 2000, Radiation research.

[40]  M. Abdelhaleem.  RNA helicases: regulators of differentiation. , 2005, Clinical biochemistry.

[41]  C. Ren,et al.  Identification of genes related to nasopharyngeal carcinoma with the help of pathway-based networks. , 2006, Acta biochimica et biophysica Sinica.

[42]  M. Vidal,et al.  Degradation of AP2 During Reticulocyte Maturation Enhances Binding of Hsc70 and Alix to a Common Site on TfR for Sorting into Exosomes , 2004, Traffic.

[43]  P. Dent,et al.  Radiation-Stimulated ERK1/2 and JNK1/2 Signaling can Promote Cell Cycle Progression in Human Colon Cancer Cells , 2005, Cell cycle.

[44]  R. Appel,et al.  Guidelines for the next 10 years of proteomics , 2009, Proteomics.

[45]  Manal M. Hassan,et al.  Effects of base excision repair gene polymorphisms on pancreatic cancer survival , 2007, International journal of cancer.

[46]  L. Oberley,et al.  Radiation-Induced Adaptive Responses Dismutase-Mediated Gene Expression in Manganese Superoxide , 2002 .

[47]  R. Legerski,et al.  The Prp19/Pso4 core complex undergoes ubiquitylation and structural alterations in response to DNA damage. , 2007, Biochemical and biophysical research communications.

[48]  H. Zhang,et al.  Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. , 2007, Cancer research.

[49]  G. Dreyfuss,et al.  Transport of Proteins and RNAs in and out of the Nucleus , 1999, Cell.

[50]  F. Hartl,et al.  Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein , 2002, Science.

[51]  C. Denkert,et al.  Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression. , 2007, Gynecologic oncology.

[52]  S. Skvortsov,et al.  Rituximab enhances radiation-triggered apoptosis in non-Hodgkin's lymphoma cells via caspase-dependent and - independent mechanisms. , 2006, Journal of radiation research.

[53]  I. Han,et al.  Ionising radiation induces changes associated with epithelial-mesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells. , 2007, European journal of cancer.

[54]  N. Kyprianou,et al.  Radiation-induced apoptosis: predictive and therapeutic significance in radiotherapy of prostate cancer (review). , 2000, Oncology reports.

[55]  M. Merino,et al.  Rab11a Differentially Modulates Epidermal Growth Factor-induced Proliferation and Motility in Immortal Breast Cells , 2006, Breast Cancer Research and Treatment.

[56]  S. Fosså,et al.  Differential expression of steroid receptors in prostate tissues before and after radiation therapy for prostatic adenocarcinoma , 2005, International journal of cancer.

[57]  R. Spang,et al.  Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues , 2007, Clinical Cancer Research.

[58]  S. Skvortsov,et al.  Antitumor activity of CTFB, a novel anticancer agent, is associated with the down-regulation of nuclear factor-κB expression and proteasome activation in head and neck squamous carcinoma cell lines , 2007, Molecular Cancer Therapeutics.

[59]  D. Troyer,et al.  Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. , 2005, Endocrine-related cancer.

[60]  P. Harari,et al.  Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. , 2000, Clinical Cancer Research.

[61]  K. Ogawa,et al.  Genetic Prognostic Index Influences Patient Outcome for Node-Positive Breast Cancer , 2006, Surgery Today.

[62]  Pingfu Fu,et al.  Activation of PI3K‐Akt signaling pathway promotes prostate cancer cell invasion , 2007, International journal of cancer.

[63]  O. Popanda,et al.  Modulation of DNA polymerases α, δ and ε by lactate dehydrogenase and 3-phosphoglycerate kinase , 1998 .

[64]  P. Wersäll,et al.  Temporary effect of arsenic trioxide treatment of refractory extragonadal germ cell cancer , 2007, Acta oncologica.

[65]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.